D. Rungta et al., REGULATION OF TYROSINASE MESSENGER-RNA CELLS BY ALPHA-MELANOCYTE-STIMULATING HORMONE, Journal of investigative dermatology, 107(5), 1996, pp. 689-693
Cloudman S-91 mouse melanoma cells respond to alpha-melanocyte-stimula
ting hormone) by demonstrating a marked increase in tyrosinase activit
y (O-diphenol-O-2 oxidoreductase, EC 1.14.18.1), This increase is the
result of increased levels of tyrosinase mRNA with a subsequent increa
se in tyrosinase abundance, Our studies were carried out to determine
the effect of melanocyte-stimulating hormone on tyrosinase gene transc
ription and to measure the kinetics of the hormone-induced increase in
tyrosinase mRNA. When melanoma cells were exposed continuously to mel
anocyte-stimulating hormone for 6 d, a large but transient increase in
both tyrosinase mRNA abundance and enzyme activity were observed, The
maximum increase in tyrosinase mRNA occurred 60 h after melanocyte-st
imulating hormone stimulation and was followed by a decline in message
levels even though cells were continuously exposed to hormone. Result
s of nuclear run-off transcription assays showed that melanocyte-stimu
lating hormone caused a slow increase in the rate of transcription of
the tyrosinase gene with a maximal 6-fold stimulation occurring at 48
h. In cells treated with the ribonucleic acid synthesis inhibitor, 5,6
-dichloro-1-beta-D-ribofuranosyl-benzimidazole, tyrosinase mRNA levels
decayed with a half-life of 4-5 h, This decay rate was unaffected by
treatment of cells with melanocyte-stimulating hormone, indicating tha
t the hormone does not act to stabilize tyrosinase ribonucleic acid. I
nhibition of protein synthesis by treatment with cycloheximide had no
effect on the melanocyte-stimulating hormone-induced increase in tyros
inase messenger ribonucleic acid levels suggesting that ongoing protei
n synthesis is not, required for, at least, the initial stimulation of
tyrosinase gene transcription by melanocyte-stimulating hormone.